Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Immunotherapy
1
Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023)
10/27/2023 3:28:49 PM |
Browse: 87 |
Download: 184
2
Progress in immunotherapy for neuroendocrine neoplasm of the digestive system
7/10/2023 8:58:21 AM |
Browse: 75 |
Download: 136
3
Immunotherapy for advanced gastric cancer
6/20/2023 11:28:13 AM |
Browse: 98 |
Download: 152
4
Low-dose immunotherapy as a potentiator to increase the response with neo-adjuvant chemotherapy in oral cancers
6/12/2023 8:16:26 AM |
Browse: 81 |
Download: 99
5
Immunotherapy for recurrent hepatocellular carcinoma
4/14/2023 1:45:13 PM |
Browse: 101 |
Download: 149
6
“Cold” colorectal cancer faces a Bottleneck in immunotherapy
2/15/2023 12:44:08 AM |
Browse: 118 |
Download: 244
7
Conversion therapy for advanced penile cancer with tislelizumab combined with chemotherapy: A case report and review of literature
11/23/2022 9:44:45 AM |
Browse: 128 |
Download: 278
8
Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review
11/21/2022 4:25:35 AM |
Browse: 191 |
Download: 329
9
Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation
11/17/2022 4:40:53 AM |
Browse: 219 |
Download: 537
10
Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy
11/10/2022 9:21:28 AM |
Browse: 176 |
Download: 541
11
Favorable response of primary pulmonary lymphoepithelioma-like carcinoma to sintilimab combined with chemotherapy: A case report
10/27/2022 4:55:05 AM |
Browse: 167 |
Download: 256
12
Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China
10/27/2022 4:55:05 AM |
Browse: 177 |
Download: 439
13
Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
10/27/2022 3:05:58 AM |
Browse: 150 |
Download: 552
14
Longest survival with primary intracranial malignant melanoma: A case report and literature review
10/21/2022 2:24:59 AM |
Browse: 180 |
Download: 334
15
Hypophysitis induced by anti-programmed cell death protein 1 immunotherapy in non-small cell lung cancer: Three case reports
10/21/2022 2:24:59 AM |
Browse: 153 |
Download: 238
16
Autoimmune encephalitis with posterior reversible encephalopathy syndrome: A case report
10/21/2022 2:24:59 AM |
Browse: 165 |
Download: 219
17
Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma
10/14/2022 12:54:50 PM |
Browse: 192 |
Download: 800
18
New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
10/14/2022 8:30:45 AM |
Browse: 183 |
Download: 371
19
Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports
9/29/2022 9:17:29 AM |
Browse: 188 |
Download: 342
20
Malignant peritoneal mesothelioma with massive ascites as the first symptom: A case report
9/27/2022 1:00:18 PM |
Browse: 388 |
Download: 370
21
Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma
9/23/2022 10:13:16 AM |
Browse: 203 |
Download: 462
22
Neoadjuvant immunotherapy in non-small-cell lung cancer: Times are changing—and fast
9/22/2022 6:32:13 AM |
Browse: 157 |
Download: 224
23
Successful treatment of stage IIIB intrahepatic cholangiocarcinoma using neoadjuvant therapy with the PD-1 inhibitor camrelizumab: A case report
9/16/2022 11:52:44 AM |
Browse: 176 |
Download: 334
24
Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer
9/9/2022 12:48:14 PM |
Browse: 170 |
Download: 671
25
Implication of gut microbiome in immunotherapy for colorectal cancer
9/9/2022 12:48:14 PM |
Browse: 186 |
Download: 627
26
Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows
9/9/2022 12:48:14 PM |
Browse: 156 |
Download: 465
27
Advances in postoperative adjuvant therapy for primary liver cancer
9/9/2022 12:48:14 PM |
Browse: 218 |
Download: 574
28
Treatment of gastric carcinoma with lymphoid stroma by immunotherapy: A case report
8/26/2022 9:54:53 AM |
Browse: 189 |
Download: 499
29
Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma
8/26/2022 9:51:35 AM |
Browse: 171 |
Download: 243
30
Paroxysmal speech disorder as the initial symptom in a young adult with anti-N-methyl-D-aspartate receptor encephalitis: A case report
8/16/2022 1:35:32 AM |
Browse: 146 |
Download: 267
31
Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”
8/1/2022 9:20:54 AM |
Browse: 253 |
Download: 611
32
Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
7/27/2022 2:48:53 AM |
Browse: 215 |
Download: 240
33
Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities
7/27/2022 2:48:53 AM |
Browse: 211 |
Download: 302
34
Short term safety of coronavirus disease 2019 vaccines in patients with solid tumors receiving systemic therapy
7/22/2022 9:38:18 AM |
Browse: 260 |
Download: 486
35
Nanomedicine approaches for treatment of hematologic and oncologic malignancies
7/22/2022 9:38:18 AM |
Browse: 232 |
Download: 467
36
Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
7/18/2022 9:47:46 AM |
Browse: 258 |
Download: 536
37
Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report
7/11/2022 8:36:01 AM |
Browse: 202 |
Download: 374
38
Advances and effectiveness of the immunotherapy after liver transplantation
6/27/2022 9:34:47 AM |
Browse: 271 |
Download: 566
39
Primary squamous cell carcinoma of the liver: A case report
6/24/2022 9:00:25 AM |
Browse: 220 |
Download: 544
40
Chidamide and sintilimab combination in diffuse large B-cell lymphoma progressing after chimeric antigen receptor T therapy
6/24/2022 9:00:24 AM |
Browse: 140 |
Download: 197
41
Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances
6/22/2022 8:29:42 AM |
Browse: 251 |
Download: 457
42
New perspectives in the management of small cell lung cancer
6/22/2022 8:29:42 AM |
Browse: 198 |
Download: 343
43
Camrelizumab-induced anaphylactic shock in an esophageal squamous cell carcinoma patient: A case report and review of literature
6/17/2022 3:19:27 AM |
Browse: 175 |
Download: 451
44
Up to seven criteria in selection of systemic therapy for hepatocellular carcinoma
6/16/2022 1:07:50 PM |
Browse: 239 |
Download: 215
45
Future therapies for pancreatic carcinoma: Insights into cancer precision medicine
6/10/2022 5:40:20 AM |
Browse: 237 |
Download: 338
46
Hepatocellular carcinoma and immunotherapy: Beyond immune checkpoint inhibitors
6/10/2022 2:05:28 AM |
Browse: 259 |
Download: 409
47
Endoscopic ultrasound-guided injectable therapy for pancreatic cancer: A systematic review
6/2/2022 12:11:47 PM |
Browse: 289 |
Download: 453
48
Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma
6/2/2022 12:11:47 PM |
Browse: 329 |
Download: 948
49
Treatment of gastric hepatoid adenocarcinoma with pembrolizumab and bevacizumab combination chemotherapy: A case report
6/2/2022 10:05:36 AM |
Browse: 228 |
Download: 387
50
Ovarian teratoma related anti-N-methyl-D-aspartate receptor encephalitis: A case series and review of the literature
6/2/2022 10:05:35 AM |
Browse: 209 |
Download: 745
Page 1 of 5 ( 209 items )
<<
1
2
3
4
5
>>
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345